Document Detail

Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis.
MedLine Citation:
PMID:  23299519     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: We sought to quantify the use of and analyze factors predictive of receipt of surgical therapy for early hepatocellular carcinoma (HCC).
BACKGROUND: The incidence of HCC is increasing, and the options for surgical therapy for early HCC have expanded, but the use of surgical therapy for early HCC has not been examined in a modern cohort.
METHODS: A retrospective cohort study was performed using data from the 1998-2007 Surveillance, Epidemiology, and End Results-Medicare linked database. Data were analyzed for patients 66 years of age and older with early HCC (tumors ≤5 cm without metastatic disease, nodal metastasis, extrahepatic extension, or major vascular invasion). Both Surveillance, Epidemiology, and End Results and Medicare data were used to ascertain receipt of therapy as well as comorbidity burden and other patient and hospital variables. Multivariable logistic regression models were used to analyze factors associated with receipt of therapy.
RESULTS: Our selection criteria identified 1745 patients for this study. Most patients had tumors between 2 and 5 cm in size (n = 1440, 83%). Solitary tumors (n = 1121, 64%) were more common than multiple tumors (n = 624, 36%). A total of 820 patients (47%) with early HCC received no surgical therapy. Among 741 patients with solitary, unilobar tumors and microscopic confirmation of HCC, 246 (33%) received no surgical therapy. Of 535 patients with no liver-related comorbidities, 273 (51%) did not receive surgical therapy. In multivariable analysis, patient age, income, tumor factors, liver-related comorbidities, and hospital factors were associated with receipt of surgical therapy.
CONCLUSIONS: Although some patients with early HCC may not be candidates for surgical therapy, these data suggest that there is a significant missed opportunity to improve survival of patients with early HCC through the use of surgical therapy.
Hari Nathan; Omar Hyder; Skye C Mayo; Kenzo Hirose; Christopher L Wolfgang; Michael A Choti; Timothy M Pawlik
Related Documents :
11595689 - Phase i trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper pept...
10091749 - Childhood melanoma survival.
17063079 - Prognostic significance of extent of ulceration in primary cutaneous melanoma.
23728679 - Percutaneous ethanol injection for liver metastases.
17397029 - Benefit of sentinel lymphadenectomy for patients with nonulcerated cutaneous melanomas ...
24496959 - Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the con...
7966799 - The role of retroperitoneal lymphadenectomy in clinical stage b testis cancer: the indi...
18661529 - Performance status and cytoreductive nephrectomy: redefining management in patients wit...
8604449 - Docetaxel (taxotere): an effective agent in the management of second-line breast cancer.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Annals of surgery     Volume:  258     ISSN:  1528-1140     ISO Abbreviation:  Ann. Surg.     Publication Date:  2013 Dec 
Date Detail:
Created Date:  2013-11-13     Completed Date:  2014-01-13     Revised Date:  2014-04-23    
Medline Journal Info:
Nlm Unique ID:  0372354     Medline TA:  Ann Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1022-7     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Carcinoma, Hepatocellular / pathology,  surgery*,  therapy
Cohort Studies
Hepatectomy / utilization*
Liver Neoplasms / pathology,  surgery*,  therapy
Retrospective Studies
SEER Program
Time Factors
United States
Grant Support

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Validity and Feasibility of the American College of Surgeons Colectomy Composite Outcome Quality Mea...
Next Document:  Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to C...